Angiotensin 2 Receptor Blocker class drugs

8 results

  • Azor

    (amlodipine besylate and olmesartan medoxomil)
    Daiichi Sankyo Inc.
    Usage: Azor is indicated for treating hypertension to lower blood pressure, either alone or with other antihypertensive agents. Effective blood pressure reduction reduces the risk of cardiovascular events such as strokes and heart attacks, with a focus on comprehensive cardiovascular risk management. Individual treatment plans should consider patient's specific risks.

  • Benicar

    (olmesartan medoxomil)
    Cosette Pharmaceuticals, Inc.
    Usage: Benicar is indicated for treating hypertension in adults and children aged six and older to lower blood pressure, reducing the risk of cardiovascular events like strokes and heart attacks. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.

  • Benicar hct

    (olmesartan medoxomil-hydrochlorothiazide)
    Cosette Pharmaceuticals, Inc.
    Usage: BENICAR HCT (olmesartan medoxomil and hydrochlorothiazide) is indicated for the treatment of hypertension to lower blood pressure. It is not intended for initial therapy and may be used alone or with other antihypertensive medications to reduce cardiovascular risk, including strokes and myocardial infarctions.

  • Edarbi

    (Azilsartan kamedoxomil)
    Azurity Pharmaceuticals, Inc.
    Usage: Edarbi is indicated for treating hypertension in adults to lower blood pressure, thereby reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.

  • Edarbyclor

    (Azilsartan kamedoxomil and chlorthalidone)
    Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
    Usage: Edarbyclor is indicated for treating hypertension to lower blood pressure, particularly in patients not adequately controlled on monotherapy. It may also serve as initial therapy for those needing multiple drugs to reach blood pressure goals, reducing the risk of cardiovascular events like strokes and heart attacks.

  • Entresto

    (Sacubitril and Valsartan)
    Novartis Pharmaceuticals Corporation
    Usage: ENTRESTO is indicated for reducing cardiovascular death and hospitalization in adults with chronic heart failure, particularly those with reduced left ventricular ejection fraction. It is also used to treat symptomatic heart failure in pediatric patients aged one year and older, aiming to improve cardiovascular outcomes.

  • Filspari

    (sparsentan)
    Travere Therapeutics, Inc.
    Usage: FILSPARI is indicated for slowing the decline of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.

  • Tribenzor

    (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide)
    Cosette Pharmaceuticals, Inc.
    Usage: Tribenzor is indicated for treating hypertension, either alone or with other antihypertensive agents, to lower blood pressure. This reduces the risk of cardiovascular events, such as strokes and myocardial infarctions. It is not intended for initial hypertension therapy and should be part of comprehensive cardiovascular risk management.